Dear
Congress: Have You Received Money From These Pharma Companies - (www.zerohedge.com)
We have been following the latest melodrama
involving a "greedy" Mylan, and numerous "humanistic" US
politicians, all the way up to the Democratic presidential candidate, exchange
blows over the company's dramatic price increases of its EpiPen anti-allergy
medication, with a healthy dose of amusement for one simple reason: if Congress
wants to crack down on someone, it should crack down on itself. After all, the
only reason Mylan has been able to pass the kinds of price increases that
Congress is now blasting it for, is because of US laws and regulations; laws
which incidentally, have been determined in Washington's backroom bribe parlor,
i.e. the corner offices of thousands of local lobby organizations dispensing
with billions of dollars in "client" funds. Clients such as the
companies listed below. Which brings us to this question: dear Congress,
have you received millions in lobby dollars from the US pharmaceutical
industry.
The canary in the coal mine for China’s
currency - (www.ft.com) The People’s Bank of China’s foreign reserves
have stopped falling and the spread between China’s onshore and offshore
exchange rates has almost vanished. The currency’s resilience, however, is unlikely to last. In particular, the amount of offshore
renminbi deposits, having peaked last year when the currency was devalued, has
continued to shrink this year despite the exchange rate becoming more stable
again. The diminishing size of the offshore market is the canary in the mine,
warning that renewed currency turbulence is likely in future. Holding the
currency outside the mainland, however, allows investors to gain exposure to
China’s economy without incurring its capital controls. The persistent decline
in offshore deposits — down by nearly a third to $180bn over the past year —
thus shows confidence in the currency remains fragile.
A Look at Some Companies Struggling With Rising
Debt - (abcnews.go.com) U.S. companies are sitting on hundreds of
billions of cash, so you might think they are in great financial shape. The
reality is different, and worrisome. Most of the cash is held by precious few
companies, a mere 1 percent of 2,000 tracked by S&P Global Ratings. At the
remaining 99 percent, finances have generally gotten worse in recent years.
Many have increased debt dramatically while their cash has barely risen, or
even fallen, among other signs of potential trouble. Here is a look at five
companies whose finances have weakened recently, according to Moody's Investors
Service, a credit-rating firm that assigns grades to companies based on their
likelihood of paying back what they owe. The companies are either one rating
change away from receiving a "junk" grade, which would make them too
risky for many investors, or have already achieved that status.
Money Market Dysfunction Helps Fuel U.S.
Corporate Bond Bonanza - (www.bloomberg.com) U.S.
companies feeling pain in short-term debt markets are seeking relief by
borrowing longer term, pushing already-high levels of corporate bond issuance
toward fresh records. Google parent Alphabet Inc. and food processor
Archer-Daniels-Midland Co. are among the companies that have sold more than $5
billion of corporate bonds in the past two months to pay off at least part of
their short-term debt known as commercial paper. They’re looking to tame their
interest expenses after new regulations have lifted some issuers’ borrowing
costs for near-term debt to seven-year highs. The changes underscore how
money-market rules that take effect in October are distorting debt markets.
Total sales for corporate bonds maturing in more than eighteen months are
around $950 billion this year, above levels for this time in 2015 and on track
to beat the full-year record of about $1.3 trillion, according to data compiled
by Bloomberg. Commercial-paper markets, where debt typically matures in 270
days or less, have shrunk by $108 billion since May, according to Federal
Reserve data.
Toxic
Mix in Asset Bubble Nirvana Hits Hedge Funds - (www.wolfstreet.com) The
toxic mix of crummy performance and high fees are having some impact. And it’s
big money: The hedge fund industry has over $3 trillion under management. And
some of this money is getting antsy. In July, hedge funds experienced net
outflows of an estimated $25.2 billion, the largest monthly net redemption
since February 2009 ($28.2 billion), according to an eVestment report
cited by Bloomberg.
In June, hedge funds got hit with net outflows of $23.5 billion. In March,
redemptions had hit $7 billion, and in January $20 billion. With some inflows
in the remaining three months, total outflows for 2016 so far amount to $55.9
billion. “Unless these pressures recede, 2016 will be the third year on record
with net annual outflows,” according to eVestment’s report. The other two years
were 2008 and 2009.
Stocks Decline on Emerging-Market Risk as U.S. Drugmakers
Tumble - (www.bloomberg.com)
Hedge Funds See Biggest Redemptions Since ’09 as Returns Lag - (www.bloomberg.com)
These Nine Charts Show Just How Quiet the Market Is Right Now - (www.bloomberg.com)
Productivity in the U.S. Looks Bad, But It's Golden Compared With Global Peers - (www.bloomberg.com)
China’s Central Bank Moves to Clamp Down on Speculation - (www.wsj.com)
Top Currency Strategy of 2016 Turns Perilous on Political Risks - (www.bloomberg.com)
The Federal Reserve Needs New Thinking - (www.wsj.com)
Hedge Funds See Biggest Redemptions Since ’09 as Returns Lag - (www.bloomberg.com)
These Nine Charts Show Just How Quiet the Market Is Right Now - (www.bloomberg.com)
Productivity in the U.S. Looks Bad, But It's Golden Compared With Global Peers - (www.bloomberg.com)
China’s Central Bank Moves to Clamp Down on Speculation - (www.wsj.com)
Top Currency Strategy of 2016 Turns Perilous on Political Risks - (www.bloomberg.com)
The Federal Reserve Needs New Thinking - (www.wsj.com)
No comments:
Post a Comment